Aaron I. Davis, Director at iTeos Therapeutics, Inc. (ITOS), sold 1,004,959 shares at $22.91 ($20.2M) on 2022-05-09, disclosed to the SEC on 2022-05-11.
Open-market sale of $20.2M ITOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.91 | 25,000 | $573K | 2.8% |
| 2 | $23.47 | 200,000 | $4.7M | 23.2% |
| 3 | $24.77 | 4,850 | $120K | 0.6% |
| 4 | $24.77 | 4,850 | $120K | 0.6% |
| 5 | $25.18 | 95,150 | $2.4M | 11.8% |
| 6 | $17.53 | 891 |
| $16K |
| 0.1% |
| 7 | $18.25 | 337,109 | $6.2M | 30.4% |
| 8 | $18.25 | 337,109 | $6.2M | 30.4% |
| Total | $20.12 avg | 1,004,959 | $20.2M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-02 | $10.2M | — | Filing → |